OpenAlex
PricingAboutJobs
Log inGet started
Work

Increased Response and Remission Rates in Short-Duration Crohn's Disease With Subcutaneous Certolizumab Pegol: An Analysis of PRECiSE 2 Randomized Maintenance Trial Data

HTML

Year: 2010
Type: article
Source: The American Journal of Gastroenterology
DOI: 10.1038/ajg.2010.78
Authors: Stefan Schreiber, Jean-Frédéric Colombel, Ralph Bloomfield, Susanna Nikolaus, Jürgen Schölmerich, Julian Panés, William J Sandborn
Institutions: Christian-Albrechts-Universität zu Kiel, University Hospital Schleswig-Holstein, Hôpital Claude Huriez, UCB Pharma (United Kingdom), University of Regensburg, Centro de Investigación Biomédica en Red, Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Mayo Clinic
Language: English

Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Keywords: Crohn's disease, certolizumab pegol, disease duration, treatment response, remission, maintenance therapy, prognostic factors, corticosteroid use, treatment timing
SDG: Good health and well-being

Open Access status: closed

Funders: Abbott Laboratories, UCB Pharma
OpenAlex ID: W2017149988
FWCI: 13.66
Cites: 26
Cited by: 235
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms